KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Emergent BioSolutions (EBS) Change in Account Payables (2016 - 2026)

Emergent BioSolutions has reported Change in Account Payables over the past 17 years, most recently at -$14.4 million for Q1 2026.

  • For Q1 2026, Change in Account Payables fell 166.67% year-over-year to -$14.4 million; the TTM value through Mar 2026 reached -$17.4 million, up 51.67%, while the annual FY2025 figure was -$8.4 million, 74.55% up from the prior year.
  • Change in Account Payables for Q1 2026 was -$14.4 million at Emergent BioSolutions, down from $11.4 million in the prior quarter.
  • Over five years, Change in Account Payables peaked at $31.0 million in Q1 2023 and troughed at -$23.0 million in Q3 2024.
  • A 5-year average of -$3.5 million and a median of -$4.2 million in 2022 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: surged 310.88% in 2023 and later plummeted 500.0% in 2025.
  • Year by year, Change in Account Payables stood at -$2.2 million in 2022, then tumbled by 222.73% to -$7.1 million in 2023, then crashed by 43.66% to -$10.2 million in 2024, then surged by 211.76% to $11.4 million in 2025, then tumbled by 226.32% to -$14.4 million in 2026.
  • Business Quant data shows Change in Account Payables for EBS at -$14.4 million in Q1 2026, $11.4 million in Q4 2025, and -$4.0 million in Q3 2025.